are all ranitidine products recalled?
121869
The FDA has requested all ranitidine (Zantac) products be pulled from the market immediately, according to a statement. The recall includes all prescription and over-the-counter ranitidine drugs as ongoing investigations uncovered levels of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, increase over time.
245028
The FDA Wednesday said that preliminary tests of alternatives including Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole) and Prilosec (omeprazole) found no N-nitrosodimethylamine (NDMA), the suspected cancer-causing agent found in OTC ranitidine drugs including the popular ...
1024798
The levothyroxine sodium product has not been recalled. We apologize to Lannett Company, its partner, Jerome Stevens Pharmaceuticals, and any patients taking this medication, for the confusion this has caused. The FDA has recalled two thyroid medications due to risks of contamination or "adulteration."
1200142
Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. The Food and Drug Administration announced Aurobindo Pharma USA, Inc. is voluntarily recalling 80 lots of Amlodipine Valsartan Tablets, Valsartan HCTZ Tablets, and Valsartan Tablets.
1330719
Update [7/27/2018] On July 13th, FDA announced a recall of certain batches of valsartan tablets because of an impurity, a chemical known as N-nitrosodimethylamine (NDMA). Valsartan is a medication commonly used to treat high blood pressure and heart failure.
565922
Valsartan Recalls. In July 2018, the FDA announced a voluntary recall of several drugs containing valsartan, used to treat high blood pressure and heart failure, because of contamination with an impurity, the potentially cancer-causing chemical N-nitrosodimethylamine, or NDMA.
1000138
Ranitidine oral tablet may cause drowsiness as well as other side effects.
352740
FDA Orders Zantac Taken Off Store Shelves Due to Cancer-Causing Chemical. Officials at the Food and Drug Administration (FDA) have ordered all ranitidine medications, sold under the brand name Zantac, taken off store shelves immediately.
449275
November 15, 2019 -- Golden State Medical Supply, Incorporated (GSMS, Inc) based upon a manufacturer's recall by Novitium Pharma LLC (Novitium), is voluntarily instituting a recall of all quantities and lots, within expiry, of Ranitidine HCl 150mg and 300mg Capsules to the consumer level because of potential presence ...
611118
Irbesartan. In July, the FDA announced a voluntary recall of irbesartan tablets. See which products were affected by the recall. In January 2019, Prinston Pharmaceutical Inc., doing business as Solco Healthcare LLC, voluntarily recalled eight llots of irbersartan-based drugs.
620018
The U.S. Food and Drug Administration has requested a manufacturer's market withdrawal of ranitidine, known commonly by the brand name Zantac. This means ranitidine products will not be available for new or existing prescriptions or over-the-counter (OTC) use in the U.S.
459882
Reddy's Laboratories, the manufacturer of Kroger, Walgreen and CVS branded ranitidine products has issued a voluntary recall. Products dated for expiration between September 2019 and June 2021 are affected. These medications are over the counter and are used to treat heartburn.
136575
Medications containing only amlodipine or HTCZ are not being recalled. Clinicians should be aware that not all lots of valsartan, irbesartan and losartan products are being recalled, and other ARBs, including candesartan, eprosartan, olmesartan and telmisartan, have not been recalled.
1261926
On October 25, 2019, AvKare announced the voluntary, consumer-level recall of prescription ranitidine due to potential contamination with N-nitrosodimethylamine (NDMA). AvKare's recall is due to the recent consumer level recall of Dr. Reddy's ranitidine products.
750303
Interactions between your drugs No interactions were found between Allergy Relief Tablets and ranitidine. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
307855
So far, there is no indication that these other products are affected; the FDA is likely asking for these tests only as a precaution. As of now, the FDA has allowed ranitidine to remain on the market. Still, some manufacturers have issued voluntary recalls and some pharmacies have pulled it off the shelves.
547042
The company had suspended sales of its generic Ranitidine tablets after the US Food and Drug Administration (USFDA) found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA.